← Back to Search

Provider Education Program for Opioid Use Disorder in Pregnant Women (STEPuP Trial)

N/A
Waitlist Available
Led By Elizabeth Krans, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Providers-
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year post delivery
Awards & highlights

STEPuP Trial Summary

This trial will test if a provider education program can help increase adoption of evidence-based practices for treating OUD during pregnancy, and improve maternal-child health outcomes.

Who is the study for?
This trial is for prenatal care providers who treat pregnant women with opioid use disorder (OUD). Providers must be English-speaking and work at obstetric sites. While patient data will be used, only a small group of English-speaking pregnant women meeting OUD criteria will be directly involved in interviews.Check my eligibility
What is being tested?
The STEPuP intervention is being tested against usual care to see if it improves the adoption of evidence-based treatments for OUD during pregnancy by prenatal providers. The goal is to enhance maternal-child health outcomes through better provider practices.See study design
What are the potential side effects?
Since this trial focuses on education and training programs for healthcare providers rather than direct medical interventions, there are no traditional side effects associated with the study.

STEPuP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I'm sorry, I need more information to understand the criterion. Can you please provide me with more context or the full criterion?

STEPuP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year post delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year post delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Medication-assisted treatment (MAT) utilization
Provider Provision of Buprenorphine
Secondary outcome measures
Breastfeeding Rate
Contraceptive Utilization Rate
Hepatitis C Virus (HCV) Screening Rate
+2 more

STEPuP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: STEPuP InterventionExperimental Treatment1 Intervention
STEPuP interventions
Group II: Usual CareActive Control1 Intervention
Standard of Care

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,341,341 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,617,593 Total Patients Enrolled
Elizabeth Krans, MDPrincipal InvestigatorUPMC Magee-Womens Hospital
1 Previous Clinical Trials
400 Total Patients Enrolled

Media Library

STEPuP Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04527926 — N/A
Opioid Use Disorder Research Study Groups: STEPuP Intervention, Usual Care
Opioid Use Disorder Clinical Trial 2023: STEPuP Intervention Highlights & Side Effects. Trial Name: NCT04527926 — N/A
STEPuP Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04527926 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there current enrollment for this clinical experiment?

"According to records on clinicaltrials.gov this trial has ceased patient recruitment as of March 17th 2022, after first being posted in September 2020. Nevertheless, there are still 658 other trials actively seeking patients at the present moment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
Elizabeth Krans, MD 2020. "STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04527926.
All > Opioid Dependence > Pregnancy
~218 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top